To increase its presence in east India, Birla Fertility & IVF, one of the top three and fastest-growing fertility and IVF chains in India, has announced the opening of its first center in Siliguri and its third in West Bengal. The growth is a component of the fertility chain’s long-term strategy to invest more than Rs 500 crore over the next years to reach 100 clinics. By acquiring two fertility chains, Birla Fertility & IVF also made a major move into South India in 2024.

Birla Fertility & IVF currently provides couples and individuals with high-quality, reasonably priced, and comprehensive fertility therapy through more than 50 facilities spread throughout 37 cities and 18 states. The far east and northeastern parts of India, such as Kalimpong, Darjeeling, Sikkim, and Assam, will be served by the new center in Siliguri. It will also be a crucial facility for patients from Bangladesh, Nepal, and Bhutan’s border areas.

As a division of the USD 3 billion CK Birla Group, Birla Fertility & IVF presently operates fertility clinics in East India in Patna, Ranchi, Bhubaneswar, Cuttack, Kolkata, Howrah, and Guwahati. The brand identified several major issues facing Siliguri, such as a lack of specialized therapies, restricted access to high-quality fertility care, and rising infertility concerns like PCOS and male infertility. By providing cutting-edge technology and skilled care, the new facility will close these gaps and serve patients from both eastern India and the surrounding areas.

The Siliguri outlet of Birla Fertility & IVF is furnished with cutting-edge equipment and a group of experts in the field. In vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and treatments for conditions like tubal blockage, PCOD, low AMH/egg count, low sperm count, and fertility preservation services like Egg Freezing are among the advanced fertility treatments it will provide to patients. The center is committed to providing outstanding clinical results and a remarkable client experience by utilizing Birla Fertility & IVF’s vast medical research and innovation capabilities.

Priyanka Dutta